Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSinovac Biotech Ltd. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.03 | -$0.03 | -$0.03 |
Sinovac Biotech Ltd. Earnings Date And Information
Sinovac Biotech Ltd. last posted its earnings results on Monday, January 30th, 2023. The company reported $-0.03 earnings per share for the quarter, missing analysts' consensus estimates of $-0.02 by $0.01. The company had revenue of 307.87 M for the quarter and had revenue of 448.27 M for the year. Sinovac Biotech Ltd. has generated $-1 earnings per share over the last year ($-1.06 diluted earnings per share) and currently has a price-to-earnings ratio of -6.45. Sinovac Biotech Ltd. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based on prior year's report dates.
Sinovac Biotech Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/29/2023 | Q1 2024 | -$1.17 | $307.87 M | $307.87 M | ||
| 08/15/2023 | Q3 2023 | $0.17 | $140.40 M | |||
| 12/29/2022 | Q1 2023 | -$3.73 | $280.47 M | |||
| 06/28/2022 | Q3 2022 | $4.87 | $1.21 B | |||
| 12/30/2021 | Q1 2022 | $33.82 | $8.39 B | |||
| 06/28/2021 | Q3 2021 | $51.45 | $10.98 B | |||
| 04/22/2021 | Q1 2021 | $1.09 | $327.45 M | |||
| 09/29/2020 | Q4 2020 | $0.10 | $115.45 M | |||
| 06/30/2020 | Q3 2020 | -$0.04 | $52.33 M | |||
| 04/30/2020 | Q2 2020 | -$0.06 | $15.39 M | |||
| 04/30/2020 | Q1 2020 | $0.22 | $81.11 M | |||
| 11/18/2019 | Q4 2019 | $0.06 | $64.34 M | |||
| 07/11/2019 | Q3 2019 | $0.11 | $64.05 M | |||
| 04/30/2019 | Q2 2019 | $0.01 | $36.55 M | |||
| 04/29/2019 | Q1 2019 | -$0.02 | $53.21 M | |||
| 11/08/2018 | Q4 2018 | $0.12 | $53.95 M | |||
| 06/29/2018 | Q3 2018 | $0.10 | $75.15 M | |||
| 05/11/2018 | Q2 2018 | $0.15 | $47.34 M | |||
| 05/11/2018 | Q1 2018 | $0.26 | $107.44 M | |||
| 06/28/2017 | Q3 2017 | $0.19 | $66.91 M |
Sinovac Biotech Ltd. Earnings: FAQ's
When is Sinovac Biotech Ltd.'s earnings date?
Sinovac Biotech Ltd. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 5th, 2025 based off last year's report dates.
How can I listen to Sinovac Biotech Ltd.'s earnings conference
call?
The conference call for Sinovac Biotech Ltd.'s latest earnings report can be listened to online.
How can I read Sinovac Biotech Ltd.'s conference call transcript?
The conference call transcript for Sinovac Biotech Ltd.'s latest earnings report can be read online.
How much revenue does Sinovac Biotech Ltd. generate each year?
Sinovac Biotech Ltd. (:SVA) has a recorded annual revenue of $448.27 M.
How much profit does Sinovac Biotech Ltd. generate each year?
Sinovac Biotech Ltd. (:SVA) has a recorded net income of $448.27 M. Sinovac Biotech Ltd. has generated $-1.06 earnings per share over the last four quarters.
What is Sinovac Biotech Ltd.'s price-to-earnings ratio?
Sinovac Biotech Ltd. (:SVA) has a price-to-earnings ratio of -6.45 and price/earnings-to-growth ratio is -0.06.